AITrading is a revolutionary trading ecosystem, which simplifies experience both for experienced traders as well as for newcomers. It gives tens millions traders the ability to live normal life while AI works for them. AITrading combines AI and Blockchain technologies with trading community capabilities on a single platform.

Crypto badges. Simple. Rewarding. Transparent. Incentivizing achievements through dedicated crypto badges. Blockchain projects are evaluated and tested for specific parameters and awarded with badges according to their achievements and contribution. The badges stand for credibility and transparency and serve to incentivize qualified projects with QCP token. The Crypto-Potential community will have access to a selection of projects with verified information and their achievements. The mission is to empower projects to achieve more. The vision is to create a more transparent crypto space.

Forget fragmented marketplaces! NOBAR is creating the first ever "Unified Crypto Commerce" to provide a holistic solution to the purchasing problem with cryptocurrency and crypto token. Our two robust functions - "Crypto Commerce" and "Shop-App" will facilitate all possible commercial activities.

Agate is the world's most comprehensive decentralized blockchain platform for instant payment without volatility risk to mainstream crypto adoption.

Safein is a blockchain-based single sign-on identity management platform ensuring security, comfort and trust for our customers. With Safein, users can easily demonstrate their true identity online where needed and control the extent of their personal data given out to various service providers.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.